Last reviewed · How we verify
NCT05194748
Diaphragmatic Thickness and Pulmonary Function in Parkinson's Disease
trial testing No intervention, observational only in Parkinson's Disease and Parkinsonism in 37 participants. Completed in 15 February 2023.
1 January 2023
Quick facts
| Lead sponsor | Abant Izzet Baysal University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 37 |
| Start date | 24 December 2021 |
| Primary completion | 1 January 2023 |
| Estimated completion | 15 February 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- No intervention, observational only
Conditions studied
- Parkinson's Disease and Parkinsonism — all drugs for Parkinson's Disease and Parkinsonism →
Sponsor
Abant Izzet Baysal University
Who can join
Adults 40 to 80, any sex, with Parkinson's Disease and Parkinsonism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Ultrasound can give important information about the morphology of the diaphragm and the amount of contraction. Our aim, with the prediction that a restrictive pathology will occur in the pulmonary function with the addition of camptocormia in Parkinson's patients; to compare respiratory functions in Parkinson's patients with and without camptocormia, to investigate the correlation between ultrasonographically measured diaphragmatic thickness and pulmonary function test values.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05194748
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention, observational only
Trials testing the same drug.
- NCT04233086 — Retrospective Observational Analysis of a Cohort With Heart Failure With Preserved Ejection Fraction · completed
Other recruiting trials for Parkinson's Disease and Parkinsonism
Currently open trials in the same condition.
- NCT07153692 — Clinical Efficacy and Mechanism of tDCS for Dysphagia in PD · NA · recruiting
- NCT06914466 — Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PD · recruiting
- NCT06400017 — Mechanism and Application of DBS in the Treatment of PD · NA · recruiting
- NCT06174948 — The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders · NA · recruiting
- NCT05934747 — Aim 3 Particle Swarm Optimization PIGD · NA · recruiting
Other Abant Izzet Baysal University trials
Trials by the same sponsor.
- NCT07374744 — Effect of Interactive Video-Based Self-Management Education in Adults With Type 2 Diabetes · NA · not yet recruiting
- NCT07524790 — The Effect of Proprioceptive Neuromuscular Facilitation on Haemodynamic Responses in a Neurological Intensive Care · NA · not yet recruiting
- NCT07507721 — Tele-Nursing-Supported Mindfetalness: Anxiety and Prenatal Attachment · NA · not yet recruiting
- NCT07509021 — Neuropathic Pain, Catastrophizing, and Adherence in SAIS · recruiting
- NCT07535177 — Gas6 and Soluble MerTK in Periodontal Diseases · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05194748 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Abant Izzet Baysal University
- Last refreshed: 26 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05194748.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing